134136-22-4Relevant articles and documents
Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and X
-
, (2014/09/03)
The present invention relates to compounds derived from sugars which reproduce the epitopes of Shigella flexneri serotypes 3a and X and to the use thereof for the preparation of vaccine compositions. More specifically, the subject matter of the present in
Synthesis of branched tri- to pentasaccharides representative of fragments of Shigella flexneri serotypes 3a and/or X O-antigens
Boutet, Julien,Guerreiro, Catherine,Mulard, Laurence A.
, p. 10558 - 10572 (2008/12/23)
Fragments of the {2)-[α-d-Glcp-(1→3)]-α-l-Rhap-(1→2)-α-l-Rhap-(1→3)-[Ac→2]-α-l-Rhap-(1→3)-β-d-GlcpNAc-(1→}n ((E)ABAcCD)n polymer were synthesized. D(E)A, CD(E)A, AcCD(E)A were obtained according to a linear strategy, whereas BCD(E)A and BAcCD(E)A were derived from the condensation of appropriate BC and D(E)A building blocks. Oligosaccharides were synthesized as their propyl glycoside, relying on (i) the efficient trichloroacetimidate chemistry, (ii) a common EA allyl glycoside, and (iii) a 2-trichloroacetamido-d-glucopyranose precursor to residue D. Final Pd/C-mediated deprotection, run under a high pressure of hydrogen, ensured O-acetyl stability. All targets are parts of the O-antigen of Shigella flexneri 3a, a prevalent serotype. Non-O-acetylated oligosaccharides are shared by the S. flexneri serotype X O-antigen.
Synthesis and NMR study of a linear pentasaccharide fragment of the Shigella flexneri 5a O-specific polysaccharide
Mulard, Laurence A,Clément, Marie-Jeanne,Segat-Dioury, Fabienne,Delepierre, Muriel
, p. 2593 - 2604 (2007/10/03)
A convergent chemical synthesis of the methyl glycoside of the linear epitope α-D-Glcp-(1→3)-α-L-Rhap-(1→3)-α-L-Rhap- (1→3)-β-D-GlcNAcp-(1→2)-α-L-Rhap (EBCDA) corresponding to the ramification of the O-antigen of Shigella flexneri serotype 5a is described